Connection

QIANG TONG to Cell Line, Tumor

This is a "connection" page, showing publications QIANG TONG has written about Cell Line, Tumor.
Connection Strength

0.242
  1. Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity. Oncogene. 2023 09; 42(36):2673-2687.
    View in: PubMed
    Score: 0.130
  2. circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression. J Exp Clin Cancer Res. 2023 Nov 23; 42(1):313.
    View in: PubMed
    Score: 0.033
  3. Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells. Sci Signal. 2020 05 26; 13(633).
    View in: PubMed
    Score: 0.026
  4. Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Sci Transl Med. 2019 05 29; 11(494).
    View in: PubMed
    Score: 0.024
  5. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget. 2015 Oct 27; 6(33):34329-41.
    View in: PubMed
    Score: 0.019
  6. The transcription factor GATA2 regulates differentiation of brown adipocytes. EMBO Rep. 2005 Sep; 6(9):879-84.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.